Deciphex had the privilege of joining a dynamic AI panel hosted by Novartis Ireland, alongside industry leaders and policymakers, to discuss the future of AI in pathology and Ireland’s role as a potential European AI hub.

This event showcased how Deciphex and Novartis, through our impactful partnership, are accelerating the use of AI for preclinical safety and drug development, leveraging vast image datasets and cutting-edge models within Patholytix.

This collaboration marks a crucial step towards harnessing AI to streamline drug development and speed up patient outcomes globally, a mission we’re proud to champion. Many thanks to Novartis for the invitation and their continued commitment to AI innovation!